SlideShare a Scribd company logo
1 of 31
Mesangial proliferative GN
• Mesangioproliferative pattern of glomerular
injury is characterized by the expansion of
mesangial matrix and the mesangial
hypercellularity. These changes can occur in
immune complex-mediated diseases, such as
IgA nephropathy or class II lupus nephritis or
non-immune diseases such as early diabetic
glomerulosclerosis, and some forms of
minimal change disease and primary focal
sclerosis.
Lupus nephritis Class II
• Histopathology:
• Mesangioproliferative pattern of glomerular injury;
the mesangium is expanded and hypercellular
• The glomerular basement membranes are of
unremarkable thickness and texture
• The tubulointerstitium is usually unremarkable
• Immunofluorescence:
• There is 'full house' reactivity (reactivity for IgG,
IgM, and IgA), with granular deposits in the
mesangium
• Electron microscopy:
• Visceral epithelial cells: Unremarkable, and the foot processes are
well preserved. Sometimes a few subepithelial deposits can be
found
• Glomerular basement membranes: Usually of normal appearance
and texture
• Glomerular endothelial cells: May contain tubuloreticular
structures. Rare, small subendothelial electron-dense deposits can
be seen scattered in a few places; if large subendothelial deposits
are seen, the proliferative forms of lupus nephritis (classes III or IV)
should be strongly considered
• Mesangium: Expanded by increase in cellular elements and
extracellular matrix with sometimes large and confluent fine
granular, electron-dense deposits
IgA
• Histopathology:
• Light microscopic examination reveals a mesangioproliferative
pattern of glomerular injury (mesangial hypercellularity and
expansion of mesangial matrix)
• The glomerular basement membranes are of unremarkable
thickness and texture
• The tubulointerstitium is usually unremarkable
• Immunofluorescence:
• There is dominant reactivity for IgA in the mesangium; C3 may
be equally or less reactive. There is usually stronger reactivity for
lambda then for kappa light chains in the mesangial deposits.
• Electron microscopy:
• Visceral epithelial cells: Usually unremarkable, and
the foot processes are well preserved
• Glomerular basement membranes: May be thin; there
is a higher incidence of thin glomerular basement
membrane disease in IgA nephropathy than in any
other glomerular disease {6}
• Glomerular endothelial cells: Usually unremarkable,
and tubuloreticular structures are not seen
• Mesangium: Increase in cellularity and extracellular
matrix, with fine granular electron-dense deposits that
are sometimes large and confluent
Resolving PIGN
• Histopathology:
• Mesangial hypercellularity and expansion
• Neutrophils are not evident, endocapillary
proliferation is not present (or is minimal)
• Some of the glomeruli may appear unremarkable
• In some cases, inflammatory process does not resolve
and results in glomerular and tubulointerstitial scarring
• Immunofluorescence:
• Coarse granular C3 reactivity in the mesangium and
along the capillary loops
• Electron microscopy:
• Visceral epithelial cells: There may be focal effacement of
foot processes
• Glomerular basement membranes: Subepithelial deposits
may be still present, particularly in areas of mesangial
notch, but subendothelial deposits have resolved
• Glomerular endothelial cells: May show non-specific
changes; tubuloreticular structures are not seen
• Mesangium: Increase in cellularity and extracellular
matrix, with sometimes large and confluent fine granular
electron-dense deposits; mesangial deposits are
predominant in resolving phase of the disease
Fibrillary GN
• Fibrillary glomerulopathy is characterized by
progressive clinical course, variable histologic
patterns (most commonly
membranoproliferative or
mesangioproliferative), with extracellular
deposition of Congo red negative material,
ultrastructurally consisting of non-branching,
randomly arranged microfibrils 12-30 nm in
diameter, usually with polyclonal IgG4
immunofluorescence reactivity.
• Etiology:
• Unclear etiology; fibrillary GN is only rarely associated with B-cell
neoplasias while the link is stronger in cases of immunotactoid
glomerulopathy {1}
• Clinical:
• Occurs more commonly in older patients (very rare in children)
and Caucasians
• There is usually nephrotic range proteinuria; other presenting
symptoms vary, including nephrotic syndrome, acute renal failure,
rapidly progressive nephritis, chronic renal insufficiency
• Outcome may be dependent on histologic pattern of injury {2}
• Histopathology:
• Commonly, there is mesangial expansion with increased mononuclear
inflammatory cells and matrix and peripheral capillary loop thickening (MPGN-like
pattern of injury); sometimes, the predominant pattern is mesangioproliferative (if
the deposition is not involving capillary loops) or even less commonly,
membranous, diffuse proliferative, or sclerosing patterns may be seen {2}
• Proliferative changes, such as increased endocapillary proliferation or crescent
formation, are uncommon but occur
• Congo red stain is negative
• Silver stain may reveal “moth eaten” appearance (non-reactive deposits admixed
with reactive matrix)
• Immunofluorescence:
• There is polyclonal deposition of IgG (most often IgG1 or IgG4) and C3 in the
mesangium and along the peripheral capillary loops; in less than 10% of cases, the
reactivity will be of monoclonal IgG; in very rare cases there will be no
immunoglobulin reactivity.
• Electron microscopy:
• Visceral epithelial cells: Focal, sometimes marked
effacement of visceral epithelial cell foot processes
• Glomerular basement membranes: Usually marked
thickening of the membranes with extensive fibrillary
deposits; the deposition extends to subepithelial,
subendothelial, and paramesangial spaces. The fibrils are
non-branching, randomly oriented, 12-30 nm in diameter
• Glomerular endothelial cells: Show loss of fenestrations
and other non-specific changes; they do not contain
tubuloreticular structures
• Mesangium: Usually expanded by matrix and organized
fibrillary deposits
Immunotactoid Glomerulopathy
• Immunotactoid glomerulopathy is a glomerular disease
characterized by deposition of abnormal proteins
(paraproteins) that are Congo red negative by light
microscopy and show microtubular or fibrillary
substructure by electron microscopy. The microtubules
are usually greater than 30 nm in diameter, sometimes
with central core, and are arranged parallel to the
glomerular basement membranes. There is usually
monoclonal immunoglobulin reactivity by
immunofluorescence. Clinically, immunotactoid
glomerulopathy is strongly associated with B-cell
lymphoproliferative disorders.
• Etiology:
• Deposition of abnormal monoclonal protein in
patients with paraproteinemia and lymphoproliferative
disorder
• Clinical:
• Usually occurs in patients over 60 years of age
• Usually presents with nephrotic range proteinuria;
other presenting symptoms vary, from nephrotic
syndrome, hematuria, acute renal failure, rapidly
progressive nephritis, chronic renal insufficiency
• Histopathology:
• Commonly, there is mesangial expansion with increased mononuclear
inflammatory cells and matrix and peripheral capillary loop thickening
(MPGN-like pattern of injury); rarely, the predominant pattern can be
mesangioproliferative (if the deposition is not involving capillary loops) or,
even less commonly, predominantly membranous
• Proliferative changes, such as increased endocapillary proliferation or
crescent formation, can be seen on rare occasions
• Congo red stain is negative
• Silver stain may reveal “moth eaten” appearance (non-reactive deposits
admixed with reactive matrix)
• Immunofluorescence:
• Monoclonal (kappa or lambda) reactivity of immunoglobulins (usually
IgG)
• Electron microscopy:
• Visceral epithelial cells: Focal, sometimes marked effacement of
visceral epithelial cell foot processes
• Glomerular basement membranes: Microtubular deposits,
frequently in parallel arrangements, can be seen in subepithelial
and intramembranous locations, extending to the paramesangial
and mesangial compartment; the basement membrane can be
affected with deposits in various degrees. The fibrils or
microtubules are non-branching, usually greater than 30 nm (10-90
nm) in diameter
• Glomerular endothelial cells: Show loss of fenestrations and other
non-specific changes; they do not contain tubuloreticular structures
• Mesangium: Usually expanded by matrix and organized
microtubular deposits
Early diabetic glomerulosclerosis
• Histopathology:
• In early diabetic glomerulosclerosis, there is mesangial expansion due to increase in amount of
matrix, with or without mesangial hypercellularity. There are no Kimmelstiel-Wilson nodules at this
stage of disease
• Peripheral capillary loops are usually of normal thickness and microaneurysms are not seen in
early stages
• Insudative lesions are usually not seen (fibrin cap, capsular drop)
• Mild patchy tubular atrophy and interstitial fibrosis and non-specific, predominantly
mononuclear cell inflammatory infiltrate
• Various degrees of vascular sclerosis and hyalinosis
• In early diabetic change, findings are milder, with mild mesangial sclerosis and mild arteriolar
hyalinosis; glomerular hypertrophy is probably the earliest sign of diabetic renal pathology
• Congo red stain is negative
• Immunofluorescence:
• Mild linear reactivity for albumin and IgG along the capillary loops; no immune deposits
• Electron microscopy:
• Visceral epithelial cells: Focal effacement of visceral
epithelial cell foot processes, in the absence of
electron-dense deposits
• Glomerular basement membranes: Usually of normal
thickness or slightly thickened
• Glomerular endothelial cells: Various non-specific
changes; do not contain tubuloreticular structures
• Mesangium: Normal cell elements and expansion of
extracellular matrix in the absence of electron-dense
deposits
Minimal Change Disease
• Can have some mesangial hypercellularity

More Related Content

What's hot

Lupus nephritis 2016
Lupus nephritis 2016Lupus nephritis 2016
Lupus nephritis 2016drsamianik
 
Chronic pyelonephritis
Chronic pyelonephritisChronic pyelonephritis
Chronic pyelonephritisLaya Pillai
 
Focal & segmental glomerulosclerosis
Focal & segmental glomerulosclerosisFocal & segmental glomerulosclerosis
Focal & segmental glomerulosclerosisMohammad Manzoor
 
NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN Sajjad Sabir
 
Interstitial nephritis,tubulointerstitial nephritis
Interstitial nephritis,tubulointerstitial nephritisInterstitial nephritis,tubulointerstitial nephritis
Interstitial nephritis,tubulointerstitial nephritisVijayDhamgay1
 
Tubulointerstitial Nephritis
Tubulointerstitial NephritisTubulointerstitial Nephritis
Tubulointerstitial Nephritisautumnpianist
 
Pediatric vasculitis dr inayat ullah
Pediatric vasculitis dr inayat ullahPediatric vasculitis dr inayat ullah
Pediatric vasculitis dr inayat ullahDr Inayat Ullah
 
Disease affecting tubules and interstitium
Disease affecting tubules and interstitiumDisease affecting tubules and interstitium
Disease affecting tubules and interstitiumessamramdan
 
Pediatric vasculitides
Pediatric vasculitidesPediatric vasculitides
Pediatric vasculitidesdattasrisaila
 
Glomerulo nephritis
Glomerulo nephritisGlomerulo nephritis
Glomerulo nephritisJijo G John
 

What's hot (20)

Glomerulonephritis (1)
Glomerulonephritis (1)Glomerulonephritis (1)
Glomerulonephritis (1)
 
Minimal change disease
Minimal change diseaseMinimal change disease
Minimal change disease
 
Lupus nephritis 2016
Lupus nephritis 2016Lupus nephritis 2016
Lupus nephritis 2016
 
Chronic pyelonephritis
Chronic pyelonephritisChronic pyelonephritis
Chronic pyelonephritis
 
Focal & segmental glomerulosclerosis
Focal & segmental glomerulosclerosisFocal & segmental glomerulosclerosis
Focal & segmental glomerulosclerosis
 
NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN
 
Interstitial nephritis,tubulointerstitial nephritis
Interstitial nephritis,tubulointerstitial nephritisInterstitial nephritis,tubulointerstitial nephritis
Interstitial nephritis,tubulointerstitial nephritis
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
CHRONIC GLOMERULONEPHRITIS
CHRONIC GLOMERULONEPHRITISCHRONIC GLOMERULONEPHRITIS
CHRONIC GLOMERULONEPHRITIS
 
Tubulointerstitial Nephritis
Tubulointerstitial NephritisTubulointerstitial Nephritis
Tubulointerstitial Nephritis
 
Pediatric vasculitis dr inayat ullah
Pediatric vasculitis dr inayat ullahPediatric vasculitis dr inayat ullah
Pediatric vasculitis dr inayat ullah
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Disease affecting tubules and interstitium
Disease affecting tubules and interstitiumDisease affecting tubules and interstitium
Disease affecting tubules and interstitium
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney Disease
 
Pediatric vasculitides
Pediatric vasculitidesPediatric vasculitides
Pediatric vasculitides
 
Uremia
UremiaUremia
Uremia
 
Hemolytic uremic syndrome
Hemolytic uremic syndrome Hemolytic uremic syndrome
Hemolytic uremic syndrome
 
Haemolytic uremic syndrome
Haemolytic uremic syndromeHaemolytic uremic syndrome
Haemolytic uremic syndrome
 
Glomerulo nephritis
Glomerulo nephritisGlomerulo nephritis
Glomerulo nephritis
 
IgA nephropathy
IgA nephropathyIgA nephropathy
IgA nephropathy
 

Viewers also liked

Viewers also liked (20)

MPGN/MCGN
MPGN/MCGNMPGN/MCGN
MPGN/MCGN
 
MPGN
MPGNMPGN
MPGN
 
Glomerular diseases
Glomerular diseases Glomerular diseases
Glomerular diseases
 
Pathology of Glomerulonephritis
Pathology of GlomerulonephritisPathology of Glomerulonephritis
Pathology of Glomerulonephritis
 
Treatment of MPGN , What is the evidence?
Treatment of  MPGN , What is the evidence?Treatment of  MPGN , What is the evidence?
Treatment of MPGN , What is the evidence?
 
Membranoproliferative glomerulonephritis, nephritic nephrotic syndrome
Membranoproliferative glomerulonephritis, nephritic nephrotic syndromeMembranoproliferative glomerulonephritis, nephritic nephrotic syndrome
Membranoproliferative glomerulonephritis, nephritic nephrotic syndrome
 
Glomerulonephritis =)
Glomerulonephritis =)Glomerulonephritis =)
Glomerulonephritis =)
 
Pathophysiology of Membranous GN
Pathophysiology of Membranous GNPathophysiology of Membranous GN
Pathophysiology of Membranous GN
 
IgA Nephropathy
IgA NephropathyIgA Nephropathy
IgA Nephropathy
 
MPGN case presentation
MPGN case presentationMPGN case presentation
MPGN case presentation
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
nephro glomerular diseases
nephro glomerular diseasesnephro glomerular diseases
nephro glomerular diseases
 
Glomerulus in health & diseases
Glomerulus in health & diseasesGlomerulus in health & diseases
Glomerulus in health & diseases
 
MPGN Pam
MPGN  PamMPGN  Pam
MPGN Pam
 
Imaging of vasculitis
Imaging of vasculitis Imaging of vasculitis
Imaging of vasculitis
 
Ophthalmoscopy
OphthalmoscopyOphthalmoscopy
Ophthalmoscopy
 
Ophthalmoscopy
OphthalmoscopyOphthalmoscopy
Ophthalmoscopy
 
Glomerulonephritis and nephrotic syndrome
Glomerulonephritis and nephrotic syndromeGlomerulonephritis and nephrotic syndrome
Glomerulonephritis and nephrotic syndrome
 
Minimal Change Disease
Minimal Change DiseaseMinimal Change Disease
Minimal Change Disease
 
Cutaneous Vasculitis
Cutaneous VasculitisCutaneous Vasculitis
Cutaneous Vasculitis
 

Similar to Mesangial proliferative GN

Glomerular Disease sem.pptx
Glomerular Disease sem.pptxGlomerular Disease sem.pptx
Glomerular Disease sem.pptxHussen39
 
Patho Kidney Presentation.pptx
Patho Kidney Presentation.pptxPatho Kidney Presentation.pptx
Patho Kidney Presentation.pptxIsratAkhi
 
glomdis - ganlin.ppt
glomdis - ganlin.pptglomdis - ganlin.ppt
glomdis - ganlin.pptMEDSeasy
 
2_18. Glomerulonephritis.pptx
2_18. Glomerulonephritis.pptx2_18. Glomerulonephritis.pptx
2_18. Glomerulonephritis.pptxssuser515ca21
 
Diffuse Proliferative GN
Diffuse Proliferative GNDiffuse Proliferative GN
Diffuse Proliferative GNedwinchowyw
 
Minimal Light Microscopic Changes
Minimal Light Microscopic ChangesMinimal Light Microscopic Changes
Minimal Light Microscopic Changesedwinchowyw
 
Focal Glomerulosclerosis
Focal GlomerulosclerosisFocal Glomerulosclerosis
Focal Glomerulosclerosisedwinchowyw
 
Glomerulonephritis1,2
Glomerulonephritis1,2Glomerulonephritis1,2
Glomerulonephritis1,2Salwa Ibrahim
 
Glomerulo
GlomeruloGlomerulo
GlomeruloCarls27
 
Basic pathology in ophthalmology
Basic pathology in ophthalmologyBasic pathology in ophthalmology
Basic pathology in ophthalmologyhawa magembe
 
486 qualitative disorders of wbc
486 qualitative disorders of wbc486 qualitative disorders of wbc
486 qualitative disorders of wbcNabin Chaudhary
 
ihdsflkjashdf;hadfhadkfhasp
ihdsflkjashdf;hadfhadkfhasp ihdsflkjashdf;hadfhadkfhasp
ihdsflkjashdf;hadfhadkfhasp me0328
 

Similar to Mesangial proliferative GN (20)

Nodular GN
Nodular GNNodular GN
Nodular GN
 
Glomerular Disease sem.pptx
Glomerular Disease sem.pptxGlomerular Disease sem.pptx
Glomerular Disease sem.pptx
 
Patho Kidney Presentation.pptx
Patho Kidney Presentation.pptxPatho Kidney Presentation.pptx
Patho Kidney Presentation.pptx
 
Renal pathology ii
Renal pathology iiRenal pathology ii
Renal pathology ii
 
Crescentic GN
Crescentic GNCrescentic GN
Crescentic GN
 
glomdis - ganlin.ppt
glomdis - ganlin.pptglomdis - ganlin.ppt
glomdis - ganlin.ppt
 
2_18. Glomerulonephritis.pptx
2_18. Glomerulonephritis.pptx2_18. Glomerulonephritis.pptx
2_18. Glomerulonephritis.pptx
 
Diffuse Proliferative GN
Diffuse Proliferative GNDiffuse Proliferative GN
Diffuse Proliferative GN
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Minimal Light Microscopic Changes
Minimal Light Microscopic ChangesMinimal Light Microscopic Changes
Minimal Light Microscopic Changes
 
Glomerular diseases
Glomerular diseasesGlomerular diseases
Glomerular diseases
 
Focal Glomerulosclerosis
Focal GlomerulosclerosisFocal Glomerulosclerosis
Focal Glomerulosclerosis
 
Diseases of the kidney
Diseases of the kidneyDiseases of the kidney
Diseases of the kidney
 
Glomerulonephritis1,2
Glomerulonephritis1,2Glomerulonephritis1,2
Glomerulonephritis1,2
 
Glomerulo
GlomeruloGlomerulo
Glomerulo
 
Basic pathology in ophthalmology
Basic pathology in ophthalmologyBasic pathology in ophthalmology
Basic pathology in ophthalmology
 
486 qualitative disorders of wbc
486 qualitative disorders of wbc486 qualitative disorders of wbc
486 qualitative disorders of wbc
 
ihdsflkjashdf;hadfhadkfhasp
ihdsflkjashdf;hadfhadkfhasp ihdsflkjashdf;hadfhadkfhasp
ihdsflkjashdf;hadfhadkfhasp
 
Nephrotic syndrome [full]
Nephrotic syndrome [full]Nephrotic syndrome [full]
Nephrotic syndrome [full]
 

More from edwinchowyw

Tubulointerstitial diseases
Tubulointerstitial diseasesTubulointerstitial diseases
Tubulointerstitial diseasesedwinchowyw
 
Focalproliferative Glomerulonephritis
Focalproliferative GlomerulonephritisFocalproliferative Glomerulonephritis
Focalproliferative Glomerulonephritisedwinchowyw
 
Basement Membrane Abnormalities
Basement Membrane AbnormalitiesBasement Membrane Abnormalities
Basement Membrane Abnormalitiesedwinchowyw
 
Humoral Immunity
Humoral ImmunityHumoral Immunity
Humoral Immunityedwinchowyw
 
Introduction to Renal Pathology
Introduction to Renal PathologyIntroduction to Renal Pathology
Introduction to Renal Pathologyedwinchowyw
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndromeedwinchowyw
 
Dry Weight Dr Rosna
Dry Weight Dr RosnaDry Weight Dr Rosna
Dry Weight Dr Rosnaedwinchowyw
 
Bartter’S And Gittleman’S Syndromes
Bartter’S And Gittleman’S SyndromesBartter’S And Gittleman’S Syndromes
Bartter’S And Gittleman’S Syndromesedwinchowyw
 
Mycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary GlomerulonephritisMycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary Glomerulonephritisedwinchowyw
 
Mycophenolate Mofetil In Relapsing Lupus Nephritis
Mycophenolate Mofetil In Relapsing Lupus NephritisMycophenolate Mofetil In Relapsing Lupus Nephritis
Mycophenolate Mofetil In Relapsing Lupus Nephritisedwinchowyw
 
Globalwarmingshow
GlobalwarmingshowGlobalwarmingshow
Globalwarmingshowedwinchowyw
 
Water And Sodium
Water And SodiumWater And Sodium
Water And Sodiumedwinchowyw
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndromeedwinchowyw
 
Membranous Nephropathy
Membranous NephropathyMembranous Nephropathy
Membranous Nephropathyedwinchowyw
 

More from edwinchowyw (20)

Membranous GN
Membranous GNMembranous GN
Membranous GN
 
Tubulointerstitial diseases
Tubulointerstitial diseasesTubulointerstitial diseases
Tubulointerstitial diseases
 
Focalproliferative Glomerulonephritis
Focalproliferative GlomerulonephritisFocalproliferative Glomerulonephritis
Focalproliferative Glomerulonephritis
 
Basement Membrane Abnormalities
Basement Membrane AbnormalitiesBasement Membrane Abnormalities
Basement Membrane Abnormalities
 
Humoral Immunity
Humoral ImmunityHumoral Immunity
Humoral Immunity
 
Introduction to Renal Pathology
Introduction to Renal PathologyIntroduction to Renal Pathology
Introduction to Renal Pathology
 
Intro Immune
Intro ImmuneIntro Immune
Intro Immune
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndrome
 
Screening
ScreeningScreening
Screening
 
Dry Weight Dr Rosna
Dry Weight Dr RosnaDry Weight Dr Rosna
Dry Weight Dr Rosna
 
Bartter’S And Gittleman’S Syndromes
Bartter’S And Gittleman’S SyndromesBartter’S And Gittleman’S Syndromes
Bartter’S And Gittleman’S Syndromes
 
Mycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary GlomerulonephritisMycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary Glomerulonephritis
 
Mycophenolate Mofetil In Relapsing Lupus Nephritis
Mycophenolate Mofetil In Relapsing Lupus NephritisMycophenolate Mofetil In Relapsing Lupus Nephritis
Mycophenolate Mofetil In Relapsing Lupus Nephritis
 
Globalwarmingshow
GlobalwarmingshowGlobalwarmingshow
Globalwarmingshow
 
Water And Sodium
Water And SodiumWater And Sodium
Water And Sodium
 
TDM MPA
TDM MPATDM MPA
TDM MPA
 
Uremic Bleed
Uremic BleedUremic Bleed
Uremic Bleed
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndrome
 
Sirolimus
SirolimusSirolimus
Sirolimus
 
Membranous Nephropathy
Membranous NephropathyMembranous Nephropathy
Membranous Nephropathy
 

Recently uploaded

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 

Recently uploaded (20)

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 

Mesangial proliferative GN

  • 2. • Mesangioproliferative pattern of glomerular injury is characterized by the expansion of mesangial matrix and the mesangial hypercellularity. These changes can occur in immune complex-mediated diseases, such as IgA nephropathy or class II lupus nephritis or non-immune diseases such as early diabetic glomerulosclerosis, and some forms of minimal change disease and primary focal sclerosis.
  • 3. Lupus nephritis Class II • Histopathology: • Mesangioproliferative pattern of glomerular injury; the mesangium is expanded and hypercellular • The glomerular basement membranes are of unremarkable thickness and texture • The tubulointerstitium is usually unremarkable • Immunofluorescence: • There is 'full house' reactivity (reactivity for IgG, IgM, and IgA), with granular deposits in the mesangium
  • 4. • Electron microscopy: • Visceral epithelial cells: Unremarkable, and the foot processes are well preserved. Sometimes a few subepithelial deposits can be found • Glomerular basement membranes: Usually of normal appearance and texture • Glomerular endothelial cells: May contain tubuloreticular structures. Rare, small subendothelial electron-dense deposits can be seen scattered in a few places; if large subendothelial deposits are seen, the proliferative forms of lupus nephritis (classes III or IV) should be strongly considered • Mesangium: Expanded by increase in cellular elements and extracellular matrix with sometimes large and confluent fine granular, electron-dense deposits
  • 5.
  • 6.
  • 7. IgA • Histopathology: • Light microscopic examination reveals a mesangioproliferative pattern of glomerular injury (mesangial hypercellularity and expansion of mesangial matrix) • The glomerular basement membranes are of unremarkable thickness and texture • The tubulointerstitium is usually unremarkable • Immunofluorescence: • There is dominant reactivity for IgA in the mesangium; C3 may be equally or less reactive. There is usually stronger reactivity for lambda then for kappa light chains in the mesangial deposits.
  • 8. • Electron microscopy: • Visceral epithelial cells: Usually unremarkable, and the foot processes are well preserved • Glomerular basement membranes: May be thin; there is a higher incidence of thin glomerular basement membrane disease in IgA nephropathy than in any other glomerular disease {6} • Glomerular endothelial cells: Usually unremarkable, and tubuloreticular structures are not seen • Mesangium: Increase in cellularity and extracellular matrix, with fine granular electron-dense deposits that are sometimes large and confluent
  • 9.
  • 10.
  • 11. Resolving PIGN • Histopathology: • Mesangial hypercellularity and expansion • Neutrophils are not evident, endocapillary proliferation is not present (or is minimal) • Some of the glomeruli may appear unremarkable • In some cases, inflammatory process does not resolve and results in glomerular and tubulointerstitial scarring • Immunofluorescence: • Coarse granular C3 reactivity in the mesangium and along the capillary loops
  • 12. • Electron microscopy: • Visceral epithelial cells: There may be focal effacement of foot processes • Glomerular basement membranes: Subepithelial deposits may be still present, particularly in areas of mesangial notch, but subendothelial deposits have resolved • Glomerular endothelial cells: May show non-specific changes; tubuloreticular structures are not seen • Mesangium: Increase in cellularity and extracellular matrix, with sometimes large and confluent fine granular electron-dense deposits; mesangial deposits are predominant in resolving phase of the disease
  • 13.
  • 14.
  • 15. Fibrillary GN • Fibrillary glomerulopathy is characterized by progressive clinical course, variable histologic patterns (most commonly membranoproliferative or mesangioproliferative), with extracellular deposition of Congo red negative material, ultrastructurally consisting of non-branching, randomly arranged microfibrils 12-30 nm in diameter, usually with polyclonal IgG4 immunofluorescence reactivity.
  • 16. • Etiology: • Unclear etiology; fibrillary GN is only rarely associated with B-cell neoplasias while the link is stronger in cases of immunotactoid glomerulopathy {1} • Clinical: • Occurs more commonly in older patients (very rare in children) and Caucasians • There is usually nephrotic range proteinuria; other presenting symptoms vary, including nephrotic syndrome, acute renal failure, rapidly progressive nephritis, chronic renal insufficiency • Outcome may be dependent on histologic pattern of injury {2}
  • 17. • Histopathology: • Commonly, there is mesangial expansion with increased mononuclear inflammatory cells and matrix and peripheral capillary loop thickening (MPGN-like pattern of injury); sometimes, the predominant pattern is mesangioproliferative (if the deposition is not involving capillary loops) or even less commonly, membranous, diffuse proliferative, or sclerosing patterns may be seen {2} • Proliferative changes, such as increased endocapillary proliferation or crescent formation, are uncommon but occur • Congo red stain is negative • Silver stain may reveal “moth eaten” appearance (non-reactive deposits admixed with reactive matrix) • Immunofluorescence: • There is polyclonal deposition of IgG (most often IgG1 or IgG4) and C3 in the mesangium and along the peripheral capillary loops; in less than 10% of cases, the reactivity will be of monoclonal IgG; in very rare cases there will be no immunoglobulin reactivity.
  • 18. • Electron microscopy: • Visceral epithelial cells: Focal, sometimes marked effacement of visceral epithelial cell foot processes • Glomerular basement membranes: Usually marked thickening of the membranes with extensive fibrillary deposits; the deposition extends to subepithelial, subendothelial, and paramesangial spaces. The fibrils are non-branching, randomly oriented, 12-30 nm in diameter • Glomerular endothelial cells: Show loss of fenestrations and other non-specific changes; they do not contain tubuloreticular structures • Mesangium: Usually expanded by matrix and organized fibrillary deposits
  • 19.
  • 20.
  • 21.
  • 22. Immunotactoid Glomerulopathy • Immunotactoid glomerulopathy is a glomerular disease characterized by deposition of abnormal proteins (paraproteins) that are Congo red negative by light microscopy and show microtubular or fibrillary substructure by electron microscopy. The microtubules are usually greater than 30 nm in diameter, sometimes with central core, and are arranged parallel to the glomerular basement membranes. There is usually monoclonal immunoglobulin reactivity by immunofluorescence. Clinically, immunotactoid glomerulopathy is strongly associated with B-cell lymphoproliferative disorders.
  • 23. • Etiology: • Deposition of abnormal monoclonal protein in patients with paraproteinemia and lymphoproliferative disorder • Clinical: • Usually occurs in patients over 60 years of age • Usually presents with nephrotic range proteinuria; other presenting symptoms vary, from nephrotic syndrome, hematuria, acute renal failure, rapidly progressive nephritis, chronic renal insufficiency
  • 24. • Histopathology: • Commonly, there is mesangial expansion with increased mononuclear inflammatory cells and matrix and peripheral capillary loop thickening (MPGN-like pattern of injury); rarely, the predominant pattern can be mesangioproliferative (if the deposition is not involving capillary loops) or, even less commonly, predominantly membranous • Proliferative changes, such as increased endocapillary proliferation or crescent formation, can be seen on rare occasions • Congo red stain is negative • Silver stain may reveal “moth eaten” appearance (non-reactive deposits admixed with reactive matrix) • Immunofluorescence: • Monoclonal (kappa or lambda) reactivity of immunoglobulins (usually IgG)
  • 25. • Electron microscopy: • Visceral epithelial cells: Focal, sometimes marked effacement of visceral epithelial cell foot processes • Glomerular basement membranes: Microtubular deposits, frequently in parallel arrangements, can be seen in subepithelial and intramembranous locations, extending to the paramesangial and mesangial compartment; the basement membrane can be affected with deposits in various degrees. The fibrils or microtubules are non-branching, usually greater than 30 nm (10-90 nm) in diameter • Glomerular endothelial cells: Show loss of fenestrations and other non-specific changes; they do not contain tubuloreticular structures • Mesangium: Usually expanded by matrix and organized microtubular deposits
  • 26.
  • 27.
  • 28. Early diabetic glomerulosclerosis • Histopathology: • In early diabetic glomerulosclerosis, there is mesangial expansion due to increase in amount of matrix, with or without mesangial hypercellularity. There are no Kimmelstiel-Wilson nodules at this stage of disease • Peripheral capillary loops are usually of normal thickness and microaneurysms are not seen in early stages • Insudative lesions are usually not seen (fibrin cap, capsular drop) • Mild patchy tubular atrophy and interstitial fibrosis and non-specific, predominantly mononuclear cell inflammatory infiltrate • Various degrees of vascular sclerosis and hyalinosis • In early diabetic change, findings are milder, with mild mesangial sclerosis and mild arteriolar hyalinosis; glomerular hypertrophy is probably the earliest sign of diabetic renal pathology • Congo red stain is negative • Immunofluorescence: • Mild linear reactivity for albumin and IgG along the capillary loops; no immune deposits
  • 29. • Electron microscopy: • Visceral epithelial cells: Focal effacement of visceral epithelial cell foot processes, in the absence of electron-dense deposits • Glomerular basement membranes: Usually of normal thickness or slightly thickened • Glomerular endothelial cells: Various non-specific changes; do not contain tubuloreticular structures • Mesangium: Normal cell elements and expansion of extracellular matrix in the absence of electron-dense deposits
  • 30.
  • 31. Minimal Change Disease • Can have some mesangial hypercellularity